Also written LDL-C
The mass of cholesterol carried inside low-density lipoprotein particles. On most panels this is calculated from other values rather than measured directly.
It remains the most widely used cardiovascular risk marker and the target of the best-evidenced preventive therapies available.
Measured in mg/dL. Each row is one claim about where your result should fall.
Long-standing US lipid guideline categories
Longevity clinics and preventive cardiology programs
| Claim | Range | Source |
|---|---|---|
| Laboratory reference range | < 100 mg/dL | Long-standing US lipid guideline categories |
| Under 70 mg/dL | < 70 mg/dL | Longevity clinics and preventive cardiology programs |
Where the sources disagree
Most LDL-C values on consumer panels are estimated using an equation, not directly assayed, and the equations become unreliable when triglycerides are high or LDL is very low. This matters for a specific reason: when a platform advertises a biomarker count, calculated values like this one are frequently counted alongside directly measured ones. If your LDL-C looks implausible next to your apoB, the equation is the likely explanation.
Each claim gets its strongest possible case before it gets its criticism. Several of these are substantially correct.
Under 70 mg/dL
Promoted by longevity clinics and preventive cardiology programs
Cumulative lifetime LDL exposure drives atherosclerosis, and trials in higher-risk groups show benefit continuing well below conventional targets.
Trial evidence for this threshold comes from people at elevated baseline risk. Extrapolating it to everyone converts a risk-stratified decision into a universal product recommendation.
One email when a reference range changes, a panel claim is corrected, or a regulatory status actually moves, not when something is merely proposed. No sponsors from any company we rate.
Unsubscribe anytime. We never sell or share your address.